Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Call for more hepatitis vaccination and treatment

  • Comment
More must be done to improve testing and treatment for hepatitis, according to a report.
The Healthcare Commission and the National Drugs Treatment Agency joint document shows results from the second of three annual reviews to assess the performance of substance misuse treatment services.

Findings were based on assessments of 149 drugs partnerships in England. They showed in 95% of partnerships, less than half of service users had a recorded test date for hepatitis C.

A further 95% of partnerships offered hepatitis B vaccinations to less than three-quarters of service users.

More out-of-hours needle exchanges are necessary, says the report, with 44% of partnerships rated as ‘weak’ in this area.

Anna Walker, the Healthcare Commission’s chief executive, said: “Partnerships must now concentrate on driving improvements in the key areas highlighted by the review, in order to provide an equal service to all patients across the country. It is also important that partnerships really understand the needs in their area for these services and provides them accordingly.”
  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.